Big cargo gene therapy
With a proven track record in biopharmaceuticals, we aim to revolutionize advanced gene therapy to address unmet patient needs.
Cancers and liver diseases
We aim to create best-in-class bacteria-based therapies for unmet patient needs. Our current therapeutic focus includes pancreatic cancer, colorectal cancer, cervical cancer and liver diseases, while we continue to seek new medical applications. Preclinical research collaborations with pharma & biotech companies are an important pillar of our strategy.